Why Shares of Solid Biosciences Are Jumping Today

Why Shares of Solid Biosciences Are Jumping Today

Shares of Solid Biosciences (NASDAQ: SLDB) are up 24% as of 11:15 a.m. EDT as the company prepares to present long-term data for three patients in a phase 1/2 study of its treatment for Duchenne muscular dystrophy. The presentation will take place at the World Muscle Society Virtual Congress. Early data suggests SGT-001 could slow or stop the progression of Duchenne muscular dystrophy regardless of how far the disease has progressed.